Portfolio company
BioSkryb
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops genomic amplification and sequencing systems for researchers and clinicians to analyse DNA and RNA from single cells.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ArgenTAG
This company develops single-cell genomic sequencing kits and barcoding technology for researchers to analyse complex biological data using long-read sequencing platforms.
Atrandi Biosciences
This company develops single-cell analysis platforms and microfluidic technologies for life science researchers in genomics, screening and biological innovation.
CS Genetics
This company develops instrument-free single-cell genomics kits for academic researchers and biopharmaceutical organisations to perform transcriptomics without expensive hardware.
Fluent
This company produces single-cell analysis kits and software for academic and clinical researchers to enable scalable genomic sequencing without complex microfluidic instrumentation.
Cellular Research
This company develops single-cell genetic analysis tools for academic and industrial researchers to quantify gene expression in individual cells.
Mission Bio
This company develops single-cell multi-omics analysis platforms for researchers and clinicians to enable precision medicine and drug development.
Cellanome
This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.
Single Cell Discoveries
This company provides single-cell sequencing and spatial transcriptomics services to pharmaceutical, biotechnology and academic organisations to support drug discovery and biological research.
